Artificial Intelligence in Drug Discovery
Podcast tekijän mukaan Simon Smith
Kategoriat:
12 Jaksot
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Julkaistiin: 7.8.2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Julkaistiin: 7.8.2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Julkaistiin: 30.7.2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Julkaistiin: 26.7.2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Julkaistiin: 18.7.2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Julkaistiin: 10.7.2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Julkaistiin: 28.6.2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Julkaistiin: 20.6.2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Julkaistiin: 11.6.2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Julkaistiin: 29.5.2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Julkaistiin: 22.5.2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Julkaistiin: 14.5.2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
